Literature DB >> 2181033

Endotoxin increases the nephrotoxic potential of gentamicin and vancomycin plus gentamicin.

M Ngeleka1, D Beauchamp, D Tardif, P Auclair, P Gourde, M G Bergeron.   

Abstract

To assess the possible role of endotoxin as an amplification factor for experimental nephrotoxicity due to gentamicin plus vancomycin, rats were given continuous intravenous (iv) endotoxin or saline followed by twice-daily intraperitoneal (ip) saline, vancomycin (20 mg/kg ip), gentamicin (15 mg/kg subcutaneously), or both gentamicin and vancomycin. After 5 or 8 days of treatment, functional and histologic parameters of renal function were evaluated: cortical drug levels, tritiated thymidine incorporation into cellular DNA, creatinine clearance, and appearance by light and electron microscopy. In animals not given endotoxin, only rats that received gentamicin plus vancomycin developed measurable abnormalities. Endotoxin did not cause nephrotoxicity in vancomycin-treated rats. However, in endotoxin-infused rats treated with gentamicin or gentamicin plus vancomycin for 8 days, the increase in blood urea nitrogen, decrease in creatinine clearance, and rise in renal cortical DNA synthesis were more severe than those in non-endotoxin-infused rats (P less than .01). In these studies, endotoxin amplified the nephrotoxic potential of gentamicin alone and gentamicin plus vancomycin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181033     DOI: 10.1093/infdis/161.4.721

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Antibiotic-induced release of endotoxin in chronically bacteriuric patients.

Authors:  J C Hurley; W J Louis; F A Tosolini; J B Carlin
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 3.  Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis.

Authors:  Abhisekh Sinha Ray; Ammar Haikal; Kassem A Hammoud; Alan S L Yu
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-28       Impact factor: 8.237

4.  Endotoxin-tobramycin additive toxicity on renal proximal tubular cells in culture.

Authors:  V Joly; Y Bergeron; M G Bergeron; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

5.  Ceftriaxone protects against tobramycin nephrotoxicity.

Authors:  D Beauchamp; G Thériault; L Grenier; P Gourde; S Perron; Y Bergeron; L Fontaine; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Increased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapy.

Authors:  M Tardif; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 7.  Glycopeptides and nephrotoxicity.

Authors:  A W Chow; R M Azar
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

8.  Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for gram-positive infections in intensive care patients.

Authors:  P Charbonneau; I Harding; J J Garaud; J Aubertin; F Brunet; Y Domart
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

9.  Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion.

Authors:  J L Kadurugamuwa; T J Beveridge
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

10.  Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling.

Authors:  D Beauchamp; P Gourde; M Simard; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.